{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:22:32Z","timestamp":1790043752002,"version":"4.0.1"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1097\/md.0b013e3182057be4","type":"journal-article","created":{"date-parts":[[2010,12,31]],"date-time":"2010-12-31T12:20:29Z","timestamp":1293798029000},"page":"52-60","source":"Crossref","is-referenced-by-count":109,"title":["Osseous Manifestations of Adult Gaucher Disease in the Era of Enzyme Replacement Therapy"],"prefix":"10.1097","volume":"90","author":[{"given":"Patrick B.","family":"Deegan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Pavlova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Tindall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penelope E.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Bearcroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derralynn","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Edmund","family":"Wraith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210309","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/BF00441877","article-title":"Effect of splenectomy on destructive bone changes in children with chronic (Type I) Gaucher disease.","volume":"145","author":"Ashkenazi","year":"1986","journal-title":"Eur J Pediatr"},{"key":"R2-5-20210309","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1600-0609.2005.00496.x","article-title":"Haemorheology in Gaucher disease.","volume":"75","author":"Bax","year":"2005","journal-title":"Eur J Haematol"},{"key":"R4-5-20210309","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/archinte.160.18.2835","article-title":"The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease.","volume":"160","author":"Charrow","year":"2000","journal-title":"Arch Intern Med"},{"key":"R5-5-20210309","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1399-0004.2007.00769.x","article-title":"The effect of enzyme replacement therapy on bone crisis and bone pain in patients with type 1 Gaucher disease.","volume":"71","author":"Charrow","year":"2007","journal-title":"Clin Genet"},{"key":"R7-5-20210309","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1182\/blood-2009-04-210112","article-title":"Vascular complications after splenectomy for hematologic disorders.","volume":"114","author":"Crary","year":"2009","journal-title":"Blood"},{"key":"R8-5-20210309","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0009-9260(05)81657-5","article-title":"Skeletal complications of type I Gaucher disease: the magnetic resonance features.","volume":"41","author":"Cremin","year":"1990","journal-title":"Clin Radiol"},{"key":"R9-5-20210309","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.bcmd.2005.05.005","article-title":"Clinical evaluation of chemokine and enzymatic biomarkers of Gaucher disease.","volume":"35","author":"Deegan","year":"2005","journal-title":"Blood Cells Mol Dis"},{"key":"R10-5-20210309","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1182\/blood-2005-12-5072","article-title":"Superior effects of high-dose enzyme replacement therapy in type 1 Gaucher disease on bone marrow involvement and chitotriosidase levels: a 2-center retrospective analysis.","volume":"108","author":"de Fost","year":"2006","journal-title":"Blood"},{"key":"R11-5-20210309","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00005650-199711000-00002","article-title":"Modeling valuations for EuroQol health states.","volume":"35","author":"Dolan","year":"1997","journal-title":"Med Care"},{"key":"R12-5-20210309","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0950-3536(97)80041-8","article-title":"Skeletal involvement in Gaucher's disease.","volume":"10","author":"Elstein","year":"1997","journal-title":"Baillieres Clin Haematol"},{"key":"R13-5-20210309","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0002-9610(91)90363-I","article-title":"A 27-year experience with splenectomy for Gaucher's disease.","volume":"161","author":"Fleshner","year":"1991","journal-title":"Am J Surg"},{"key":"R14-5-20210309","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s11136-004-0794-y","article-title":"Quality of life related to type 1 Gaucher disease: Spanish experience.","volume":"14","author":"Giraldo","year":"2005","journal-title":"Qual Life Res"},{"issue":"334","key":"R15-5-20210309","first-page":"43","article-title":"Thrombophilia and hypofibrinolysis: pathophysiologies of osteonecrosis.","author":"Glueck","year":"1997","journal-title":"Clin Orthop Relat Res"},{"issue":"137","key":"R16-5-20210309","first-page":"208","article-title":"The orthopedic aspects of Gaucher disease.","author":"Goldblatt","year":"1978","journal-title":"Clin Orthop Relat Res"},{"key":"R17-5-20210309","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1172\/JCI117084","article-title":"Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease.","volume":"93","author":"Hollak","year":"1994","journal-title":"J Clin Invest"},{"key":"R18-5-20210309","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jbspin.2006.01.025","article-title":"Pathophysiology and natural history of avascular necrosis of bone.","volume":"73","author":"Lafforgue","year":"2006","journal-title":"Joint Bone Spine"},{"key":"R20-5-20210309","first-page":"177","article-title":"The pathology of Gaucher disease.","volume":"95","author":"Lee","year":"1982","journal-title":"Prog Clin Biol Res"},{"key":"R21-5-20210309","first-page":"37","article-title":"Orthopaedic manifestations of Gaucher disease.","volume":"65","author":"Lutsky","year":"2007","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"R22-5-20210309","first-page":"318","article-title":"Radiology of Gaucher disease (type 1) and bone manifestations: the Dutch experience.","volume":"89","author":"Maas","year":"2006","journal-title":"JBR-BTR"},{"issue":"Suppl 1","key":"R23-5-20210309","doi-asserted-by":"crossref","first-page":"A13","DOI":"10.1259\/bjr.75.suppl_1.750013","article-title":"Imaging and quantifying skeletal involvement in Gaucher disease.","volume":"75","author":"Maas","year":"2002","journal-title":"Br J Radiol"},{"key":"R24-5-20210309","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2141.2009.07872.x","article-title":"Timing of initiation of enzyme replacement therapy after diagnosis of type 1 Gaucher disease: effect on incidence of avascular necrosis.","volume":"147","author":"Mistry","year":"2009","journal-title":"Br J Haematol"},{"key":"R25-5-20210309","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11926-000-0059-x","article-title":"Bone and joint complications related to Gaucher disease.","volume":"2","author":"Pastores","year":"2000","journal-title":"Curr Rheumatol Rep"},{"key":"R26-5-20210309","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1002\/jbmr.5650111125","article-title":"Bone density in Type 1 Gaucher disease.","volume":"11","author":"Pastores","year":"1996","journal-title":"J Bone Miner Res"},{"key":"R28-5-20210309","first-page":"138","article-title":"Risk factors for osteonecrosis in patients with type 1 Gaucher's disease.","volume":"145","author":"Rodrigue","year":"1986","journal-title":"Clin Orthop Relat Res"},{"key":"R29-5-20210309","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.2214\/ajr.139.6.1202","article-title":"Accelerated skeletal deterioration after splenectomy in Gaucher type 1 disease.","volume":"139","author":"Rose","year":"1982","journal-title":"AJR Am J Roentgenol"},{"key":"R30-5-20210309","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1001\/archsurg.1983.01390080037011","article-title":"The role of splenectomy in Gaucher's disease.","volume":"118","author":"Shiloni","year":"1983","journal-title":"Arch Surg"},{"key":"R31-5-20210309","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1399-0004.2008.00978.x","article-title":"Improvement of bone disease by imiglucerase (Cerezyme) therapy in patients with skeletal manifestations of type 1 Gaucher disease: results of a 48-month longitudinal cohort study.","volume":"73","author":"Sims","year":"2008","journal-title":"Clin Genet"},{"key":"R32-5-20210309","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00005792-198509000-00003","article-title":"Skeletal complications of Gaucher disease.","volume":"64","author":"Stowens","year":"1985","journal-title":"Medicine (Baltimore)"},{"key":"R33-5-20210309","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.bbadis.2007.04.002","article-title":"Increased plasma macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels in type 1 Gaucher disease.","volume":"1772","author":"van Breemen","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"R34-5-20210309","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/ajh.21280","article-title":"A benchmark analysis of the achievement of therapeutic goals for type 1 Gaucher disease patients treated with imiglucerase.","volume":"83","author":"Weinreb","year":"2008","journal-title":"Am J Hematol"},{"key":"R35-5-20210309","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0002-9343(02)01150-6","article-title":"Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry.","volume":"113","author":"Weinreb","year":"2002","journal-title":"Am J Med"},{"issue":"Suppl 1","key":"R36-5-20210309","doi-asserted-by":"crossref","first-page":"A2","DOI":"10.1259\/bjr.75.suppl_1.750002","article-title":"Skeletal aspects of Gaucher disease: a review.","volume":"75","author":"Wenstrup","year":"2002","journal-title":"Br J Radiol"},{"key":"R37-5-20210309","first-page":"80","article-title":"Children with type I Gaucher disease: growing into adulthood with and without enzyme therapy.","volume":"2","author":"Zimran","year":"2000","journal-title":"Isr Med Assoc J"},{"key":"R38-5-20210309","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00005792-199211000-00002","article-title":"Gaucher disease. Clinical, laboratory, radiologic, and genetic features of 53 patients.","volume":"71","author":"Zimran","year":"1992","journal-title":"Medicine (Baltimore)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0b013e3182057be4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:48:26Z","timestamp":1786042106000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005792-201101000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0b013e3182057be4","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}